| Zita | Tirzepatide Jekiseni Poda |
| Kuchena | 99% |
| Chitarisiko | White Lyophilized Powder |
| Administration | Subcutaneous Injection |
| Size | 10mg, 15mg, 20mg, 30mg, 60mg |
| Mvura | 3.0% |
| Benefits | Kurapa Chirwere cheshuga, Kuderedza Uremu |
Tirzepatide Lyophilized Powder (60 mg)
Tirzepatide (LY3298176) ndiyo yekutanga mbiri-acting agonist inotarisa zvose GIP (glucose-dependent insulinotropic polypeptide) uye GLP-1 (glucagon-like peptide-1) receptors. Yakagamuchira kubvumidzwa kweUS FDA muna Chivabvu 2022 kurapwa kwerudzi rwechipiri chirwere cheshuga mellitus (T2DM) sechinhu chinopindirana nekudya uye maekisesaizi.
Ichi chigadzirwa chinopihwa se60mg lyophilized (yakaomeswa-yakaomeswa) isina kuomeswa poda mumidziyo, iyo inofanirwa kuvandudzwa nemvura ine bacteriostatic isati yaitwa. Kana ichienzaniswa neiyo imwe chete GLP-1 receptor agonists semaglutide kana dulaglutide, tirzepatide inoratidza hukuru hwepamusoro mukuvandudza kurongeka kweglucose yeropa, kuwedzera insulin senitivity, uye kutsigira uremu hwakakura. Aya mabhenefiti anoverengerwa kune ayo maviri-receptor synergistic maitiro ekuita.
Key Benefits
Glycemic Control
Weight Management
Utano Hwomwoyo
Kushandisa uye Dosage
Type 2 Chirwere cheshuga
Kufutisa / Weight Management
Yakakurudzirwa Dosage Kuenzanisa
| Indication | Kutanga Dose | Titration Chirongwa | Common Dose | Maximum Dose | Frequency |
|---|---|---|---|---|---|
| Type 2 Chirwere cheshuga | 2.5 mg vhiki nevhiki | Wedzera mavhiki mana ega ega (→ 5 → 7.5 → 10 → 12.5 → 15 → 20 → 30 → 45 → 60) | 10-30 mg vhiki nevhiki | 60 mg vhiki nevhiki | Kamwe pavhiki |
| Kufutisa / Kuderedza uremu | 2.5 mg vhiki nevhiki | Kuwedzera kunoenderana nekushivirira (2.5 → 5 → 7.5 → 10 → 12.5 → 15 → 20 → 30 → 45 → 60) | 30-60 mg vhiki nevhiki | 60 mg vhiki nevhiki | Kamwe pavhiki |
Cherechedza:Ita shuwa kuti imwe neimwe yapfuura dose inobvumirwa zvakanaka isati yakwira.
Zvingangoitika Zvakaipa
Pharmacokinetics
Summary
Tirzepatide 60 mg lyophilized poda inomiririra chizvarwa chinotevera chekurapa kufambira mberi, kusanganisa ine simba glycemic control nehuremu hunoshamisa hunoshanda uye inogona kudzivirira yemoyo.
Iine zvishoma nezvishoma titration purogiramu (2.5 mg → kusvika ku60 mg), inobvumira kuwedzerwa kushivirira uye kushanduka kwekurapa kwega. Kutonga kwayo kamwe-vhiki nevhiki kunonatsiridza kutevedzera, zvichiita kuti ive sarudzo itsva uye inoshanda kune manejimendi yerudzi rwechipiri chirwere cheshuga uye kufutisa mumakiriniki epamusoro uye ekutsvaga.